Glossary of terms used in drug policy

This Glossary is an alphabetical list of terms used in a domain of drug policy, with the definitions for those terms. It contains explanations of concepts and terms related to the field of drugs and relevant related matters. We hope that it will contribute to better understanding the drug problem in a more empathic manner.

The Glossary should serve firstly to member organisations in a way that will help in process of harmonization of opinions and attitudes. This material will also serve a wider range of groups of people including policy makers, stakeholders, activists, the media, police, judiciary and others.

You can also download a PDF version of the Glossary in English (version December 2018), following this link>>>

Disclaimer: The Glossary will be updated from time to time. If you find difficulties in understanding some other terms used in drug policy or think that a term should be explained, please don’t hesitate to contact DPNSEE and we shall be more than happy to find a definition and add it to the Glossary. If you think that some term is missing, please add the word here:


ABCDEFGHIJKLMNOPQRSTUVWXYZ#

A

Acquired immunodeficiency syndrome (AIDS)

Addiction

Agonist

Antagonist

Antiretroviral therapy (ART)

C

Club (party) drugs

CND – Commission on narcotic drugs

Comorbidity

D

Depenalisation

Dependence

Detoxificiation

Diversion

Drug

Drug abuse prevention programmes

Drug demand reduction

Drug policy

Drug prevention

Drug treatment

Drug use

Drug-induced deaths

E

EHRA – Eurasian Harm Reduction Association

EMCDDA – European Monitoring Centar for Drugs and Drug Addiction

Ethical dug prevention

Evidence based (evidence informed)

Evidence-based drug prevention

H

Hallucinogens

Harm reduction (Harm minimization)

Hepatitis C (HCV)

Heroin-assisted treatment (HAT)

Human immunodeficiency virus (HIV)

Human rights-based approach

I

Iatrogenic effect

IDPC – International Drug Policy Consortium

Illicit drugs

INCB – International Narcotics Control Board

Incidence

Incidence rates

Indicated prevention

Injection drug use (IDU)

L

Legal high

Legalisation

M

Mandatory treatment

Methadone (MTD)

N

NA – Narcotics Anonymous

Naloxone

Needle distribution program

Needle exchange programs (NEP)

Needle-sharing

New Psychoactive Substances (NPS)

O

Opiate

Opioid

Opioid substitution therapy (OST)

Overdose

P

Pompidou Group

PrEP (Pre-Exposure Prophylaxis)

Problem drug use

Prohibition

Psychoactive plant

Psychoactive substance

Public health approach

R

Receptor

Recidivism

Recreational drug use

Regulation

Rehabilitation

Reitox – European information network on drugs and drug addiction

Relapse

Remission

Risk factors and protective factors

S

Selective prevention

Social Determinants of Health

Stigmatization

Stimulants

Substance use disorder

Substitution treatment

Supply reduction

Synthetic cannabinoids

Synthetic cathinones

T

TAIEX

Therapeutic community

Tiered prevention

Tolerance

Tranquillizer

Treatment centre

Treatment demand indicator (TDI)

U

UN drug conventions

UNDCP – United Nations Drug Control Program

Universal prevention

UNODC – United Nations Office on Drugs and Crime

W

War on drugs

WHO – World Health Organization

 

 


With the support of the member organisations, DPNSEE will continue preparing versions in various local SEE languages.